Header Logo

Connection

Philip Liebson to Angiotensin-Converting Enzyme Inhibitors

Back to Details
This is a "connection" page, showing publications Philip Liebson has written about Angiotensin-Converting Enzyme Inhibitors.
Philip Liebson
Connection Strength
0.681
Angiotensin-Converting Enzyme Inhibitors
  1. VALIANT and EUROPA. Prev Cardiol. 2004; 7(1):42-4.
    View in: PubMed
    Score: 0.228
  2. VISP and INVEST. Prev Cardiol. 2004; 7(2):93-6.
    View in: PubMed
    Score: 0.228
  3. Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET): implications for reduced cardiovascular risk. Prev Cardiol. 2009; 12(1):43-50.
    View in: PubMed
    Score: 0.081
  4. ENHANCE and ONTARGET. Prev Cardiol. 2008; 11(3):179-82.
    View in: PubMed
    Score: 0.075
  5. Calcium channel blockers in the spectrum of antihypertensive agents. Expert Opin Pharmacother. 2006 Dec; 7(17):2385-401.
    View in: PubMed
    Score: 0.070
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.